Synergy Pharmaceuticals Initiates Phase 2 Study of SP-333 in Patients With Opioid-Induced Constipation
Synergy Pharmaceuticals Initiates Phase 2 Study of SP-333 in Patients with Opioid-Induced Constipation
Synergy Pharmaceuticals Inc. today announced the start of a phase 2 clinical trial to evaluate the safety and efficacy of SP-333, its second-generation GC-C agonist a
Methadone Symptoms – Yahoo News Search Results
Sucampo and Takeda Initiate Pivotal Trial of Lubiprostone Liquid Formulation in Adults With Chronic Idiopathic …
BETHESDA, Md. and DEERFIELD, Ill. — Sucampo Pharmaceuticals, Inc. ("Sucampo") and its development and commercialization partner Takeda Pharmaceuticals U.S.A., Inc. (Takeda) today announced that …
Methadone Symptoms – Yahoo News Search Results
New clinic aims to reduce stigma around opioid addiction
With fentanyl and other opioid abuse becoming more of an issue in the Ottawa area, one treatment centre is taking an innovative approach to helping people with prescription drug problems.
Methadone Symptoms – Yahoo News Search Results
Find More Methadone Symptoms Information…